preferred drug
Scope
Date
~
-
Culture & Trends
Average is over; microsegment consumers, professor says
The phrase “Average is over” topped the list of 10 key phrases suggested by a renowned Korean consumer behavior professor to predict 202...
Oct 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Sanofi, Korean biotech Lemonex ink material transfer agreement
South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...
Sep 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Aerospace & Defense
Korea eyes $3.8 billion in Redback armored vehicle exports to Australia
South Korea is expected to clinch a deal to export more than 5 trillion won ($3.8 billion) worth of armored vehicles to Australia, which is strength...
Aug 31, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Korean teens prefer TikTok over KakaoTalk, says survey
South Korean teens appear to prefer to do their social networking on TikTok over KakaoTalk, as short-form videos surge in popularity worldwide. ...
Aug 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare logs record-high Q2 revenue on back of Remsima
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...
Aug 17, 2022 (Gmt+09:00)
-
Culture & Trends
MZers become key consumers of ergonomic office chairs, Sidiz says
Ergonomic office chairs are drawing heightened interest from millennials and Generation Zers in South Korea, according to the country’s leadin...
Aug 12, 2022 (Gmt+09:00)
-
Bio & Pharma
TiumBio inks licensing deal with China's Hansoh for endometriosis drug
South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...
Aug 10, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Brookfield likely to beat KKR for $800 mn Korean gas facility
Brookfield Asset Management has entered talks with South Korea's SK Materials Airplus Inc. to buy the latter's industrial gas facility, after its pr...
Aug 07, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Hanwha Aerospace, Hanwha Defense likely to merge
Hanwha, the South Korean chemicals-to-financial conglomerate, has been a key player in the M&A market with a series of conspicuous acquisitions ...
Jul 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Alternative investments
Korean firms eye alternative assets for safer investments, survey finds
South Korean corporates are increasingly eyeing alternative assets seeking downside protection amid interest rate hikes and equity and bond price dr...
Jul 11, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
KG-led consortium named preferred buyer of Ssangyong Motor
A consortium led by chemicals-to-steel conglomerate KG Group has been named the preferred buyer of South Korea’s troubled sport utility vehicl...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
KKR to buy SK’s gas production facility for more than $785 mn
KKR & Co., a global private equity firm, is set to buy South Korean conglomerate SK Group’s industrial gas production facility at slightly...
May 11, 2022 (Gmt+09:00)
-
Real estate
Mirae Asset named preferred bidder for IFC Seoul
Mirae Asset Global Investments Co., an asset management arm of Mirae Asset Financial Group in South Korea, will be in an exclusive talk with Brookfi...
May 11, 2022 (Gmt+09:00)
-
Korean Investors
73% of LPs to ramp up global warehouse investment
Key asset owners of South Korea are eyeing logistics centers and multifamily housing for real estate investing while planning to reduce exposure to ho...
Apr 26, 2022 (Gmt+09:00)
-
Korean Investors
Direct lending remains the top PD strategy for Korean LPs
Around 70% of South Korean key asset owners will expand their exposure to global private debt, expecting steady streams of cash flow, according to a r...
Apr 19, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Korean Investors
Healthcare, tech top Korean LPs' favorite PE sectors
Healthcare and technology are the preferred sectors for global private equity investment, a survey of South Korea's major asset owners has shown. Co-i...
Apr 06, 2022 (Gmt+09:00)
-
Korean Investors
Healthcare, tech top Korean LPs' favorite PE sectors
Healthcare and technology are the preferred sectors for global private equity investment, a survey of South Korea's major asset owners has shown. Co-i...
Apr 06, 2022 (Gmt+09:00)
-
Corporate strategy
SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors
South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...
Mar 28, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Upcoming IPOs
Korea’s Voronoi in talks with global firms on drug designs
South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...
Mar 04, 2022 (Gmt+09:00)
-
M&As
Lotte Group beats Shinsegae to acquire Ministop Korea
Lotte Group beat its retail rival Shinsegae Group in a competition to buy South Korea’s fifth-largest convenience store chain Ministop Korea. ...
Jan 17, 2022 (Gmt+09:00)